Menzaghi, C.* ; Marucci, A.* ; Mastroianno, M.* ; Di Ciaccia, G.* ; Armillotta, M.P.* ; Prehn, C. ; Salvemini, L.* ; Mangiacotti, D.* ; Adamski, J. ; Fontana, A.* ; De Cosmo, S.* ; Lamacchia, O.* ; Copetti, M.* ; Trischitta, V.*
Inflammation and prediction of death in type 2 diabetes. Evidence of an intertwined link with tryptophan metabolism.
J. Clin. Endocrinol. Metab. 110, e1323-e1333 (2024)
OBJECTIVE: To study whether inflammation is associated with and helps predict mortality risk in patients with type 2 diabetes. To explore the intertwined link between inflammation and tryptophan metabolism on death risk. DESIGN: Two prospective cohorts: the aggregate Gargano Mortality Study (1,731 individuals; 872 all-cause deaths) as discovery sample, the Foggia Mortality Study (490 individuals; 256 deaths) as validation sample. Twenty-seven inflammatory markers were measured. Causal mediation analysis and in vitro studies were carried out to explore the link between inflammatory markers and the kynurenine-to-tryptophan ratio (KTR) in shaping mortality risk. RESULTS: Using multivariable stepwise Cox regression analysis, IL-4, IL-6, IL-8, IL-13, RANTES and IP-10, were independently associated with death. An inflammation score (I-score) comprising these six molecules is strongly associated with death in both the discovery and the validation cohorts HR (95%CI) = 2.13 (1.91-2.37) and 2.20 (1.79-2.72), respectively. The I-score improved discrimination and reclassification measures (all P<0.01) of two mortality prediction models based on clinical variables. The causal mediation analysis showed that 28% of the KTR effect on mortality was mediated by IP-10. Studies in cultured endothelial cells showed that 5-Methoxy-tryptophan, an anti-inflammatory metabolite derived from tryptophan, reduces the expression of IP-10, thus providing a functional basis for the observed causal mediation. CONCLUSIONS: Adding the I-score to clinical prediction models may help identify individuals who are at greater risk of death. Deeply addressing the intertwined relationship between low-grade inflammation and imbalanced tryptophan metabolism in shaping mortality risk may help discover new therapies targeting patients characterized by these abnormalities.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Ip-10 ; Death Risk ; Inflammation Risk Score ; Prediction Models ; Tryptophan Pathway; Individual Participant Data; Risk Equations; Mortality; Complications; Validation; Disease; Curve
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
0021-972X
e-ISSN
1945-7197
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 110,
Heft: 5,
Seiten: e1323-e1333
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Endocrine Society
Verlagsort
Bethesda, Md.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
Forschungsfeld(er)
Enabling and Novel Technologies
Genetics and Epidemiology
PSP-Element(e)
A-630710-001
G-500600-001
Förderungen
EFPIA
European Union
Innovative Medicines Initiative 2 Joint Undertaking (JU)
European Health Data & Evidence Network (EHDEN) project
Ministero della Salute
Ministero dell' Universita PNRR M4C2I1.3 Heal Italia project
Ministero dell' Istruzione dell'Universita (PRIN)
Copyright
Erfassungsdatum
2024-09-03